Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease.
Ploussard G, Fiard G, Barret E, Brureau L, Créhange G, Dariane C, Fromont G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Rozet F, Ruffion A, Sargos P, Beauval JB, Rouprêt M. Ploussard G, et al. Among authors: crehange g. Prog Urol. 2022 Nov;32(15):1275-1372. doi: 10.1016/j.purol.2022.07.148. Prog Urol. 2022. PMID: 36400483 Review.
Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).
Sargos P, Guerif S, Latorzeff I, Hennequin C, Pommier P, Lagrange JL, Créhange G, Chapet O, de Crevoisier R, Azria D, Supiot S, Habibian M, Soulié M, Richaud P. Sargos P, et al. Among authors: crehange g. Cancer Treat Rev. 2015 Dec;41(10):814-20. doi: 10.1016/j.ctrv.2015.10.005. Epub 2015 Oct 23. Cancer Treat Rev. 2015. PMID: 26508669 Review.
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Carrie C, Hasbini A, de Laroche G, Richaud P, Guerif S, Latorzeff I, Supiot S, Bosset M, Lagrange JL, Beckendorf V, Lesaunier F, Dubray B, Wagner JP, N'Guyen TD, Suchaud JP, Créhange G, Barbier N, Habibian M, Ferlay C, Fourneret P, Ruffion A, Dussart S. Carrie C, et al. Among authors: crehange g. Lancet Oncol. 2016 Jun;17(6):747-756. doi: 10.1016/S1470-2045(16)00111-X. Epub 2016 May 6. Lancet Oncol. 2016. PMID: 27160475 Clinical Trial.
[Prostate cancer brachytherapy].
Pommier P, Guérif S, Peiffert D, Créhange G, Hannoun-Lévi JM, de Crevoisier R. Pommier P, et al. Among authors: crehange g. Cancer Radiother. 2016 Sep;20 Suppl:S210-5. doi: 10.1016/j.canrad.2016.07.038. Epub 2016 Aug 11. Cancer Radiother. 2016. PMID: 27523412 French.
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study.
De Bari B, Stish B, Ball MW, Habboush Y, Sargos P, Krengli M, Bossi A, Stabile A, Sole Pesutic C, Lestrade L, Smeenk RJ, Jereczek-Fossa BA, Zilli T, Créhange G, Alongi F, Zaorsky N, Ozsahin M. De Bari B, et al. Among authors: crehange g. Prostate. 2017 Jul;77(10):1160-1166. doi: 10.1002/pros.23375. Epub 2017 Jun 8. Prostate. 2017. PMID: 28594087
235 results